Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-089342
Filing Date
2024-08-01
Accepted
2024-08-01 16:30:28
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-20240630.htm   iXBRL 10-Q 2526870
2 EX-31.1 adpt-ex31_1.htm EX-31.1 17185
3 EX-31.2 adpt-ex31_2.htm EX-31.2 17179
4 EX-32.1 adpt-ex32_1.htm EX-32.1 10252
5 EX-32.2 adpt-ex32_2.htm EX-32.2 11423
  Complete submission text file 0000950170-24-089342.txt   10094829

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20240630.xsd EX-101.SCH 1187129
80 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20240630_htm.xml XML 2091445
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 241167234
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)